Zobrazeno 1 - 10
of 158
pro vyhledávání: '"Otero MJ"'
Autor:
Fermín Sánchez-Guijo, Silvia Jiménez Cabrera, Otero Mj, Aránzazu Zarzuelo Castañeda, Álvaro Corral Alaejos, Jonás Samuel Pérez-Blanco
Publikováno v:
British Journal of Clinical Pharmacology. 88:1913-1924
Aims Imatinib is considered the standard first line treatment in newly diagnosed patients with chronic-phase myeloid leukaemia (CML). Several imatinib population pharmacokinetic (popPK) models have been developed. However, their predictive performanc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a2f208d738dddce7b7aae887f806bfde
https://doi.org/10.1111/bcp.15122
https://doi.org/10.1111/bcp.15122
Autor:
María Dolores Toscano Guzmán, M. Galván-Banqueri, Jesus Martinez-Sotelo, Otero Mj, María Dolores Santos-Rubio
Publikováno v:
Eur J Hosp Pharm
Objective To determine the utility of a tool (TRIGGER-CHRON) for identifying adverse drug events (ADEs) associated with the administration of high-alert medications in elderly patients with multimorbidity and to determine the medications most frequen
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::82575aca083c27b7a3efeb9f4d4e321b
https://doi.org/10.1136/ejhpharm-2019-002126
https://doi.org/10.1136/ejhpharm-2019-002126
Autor:
José Germán Sánchez-Hernández, Nerea Martín-Gutiérrez, Alejandra F Pordomingo, Noemí Rebollo, Fernando Muñoz, Otero Mj
Publikováno v:
Eur J Hosp Pharm
OBJECTIVE: Switching patients from the originator infliximab to a biosimilar is a measure to expand access to treatments and counteract its negative impact on healthcare budgets. However, industry-independent long-term studies on the effect of switch
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f16e9d3e16959a58f63f1f566a045d8f
https://europepmc.org/articles/PMC9251170/
https://europepmc.org/articles/PMC9251170/
Autor:
Lourdes Vázquez-López, José Germán Sánchez-Hernández, Noemí Rebollo, Otero Mj, Aranzazu Zarzuelo-Castañeda, Diego Peña-Lorenzo, Jonás Samuel Pérez-Blanco
Publikováno v:
European Journal of Pharmaceutical Sciences. 168:106049
Background Posaconazole is an antifungal agent extensively used as a prophylaxis for invasive fungal infections (IFIs) in allogeneic stem cell transplant (SCT) recipients. Low posaconazole concentrations have been associated with reduced clinical res
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::624620b7ecc9e0613854b4be1da9d1c3
https://doi.org/10.1016/j.ejps.2021.106049
https://doi.org/10.1016/j.ejps.2021.106049
Autor:
De-Blas I, Lou Bonafonte Jm, Puente-Lanzarote Jj, Lorente-Pérez S, Andrés-Otero Mj, Eguiluz M, Soria M
Publikováno v:
Archives of Hepatitis Research. 3:001-003
The unintentional discovery of cirrhosis in a patient with prostate cancer lead us to enquire if some of the indexes/scored designed for the evaluation of liver fi brosis/cirrhosis, in Chronic Hepatitis C patients, could have helped us in the detecti
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5513cb494227e0e91d34af8026305fd9
https://doi.org/10.17352/ahr.000007
https://doi.org/10.17352/ahr.000007
Publikováno v:
European Journal of Pharmaceutical Sciences. 153:105484
The present study aimed to establish a population pharmacokinetic (PopPK) model of Phenobarbital (PB) in Caucasian patients with epilepsy included in a Therapeutic Drug Monitoring program. In total, 855 PB serum concentrations (steady-state trough co
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::230eda255c9a25b6739675f8a1fcb38b
https://doi.org/10.1016/j.ejps.2020.105484
https://doi.org/10.1016/j.ejps.2020.105484
Autor:
Susana Sánchez Fidalgo, María Concepción Pérez Guerrero, Mercedes Galván Banqueri, María Dolores Toscano Guzmán, Isabel Font Noguera, Otero Mj
Publikováno v:
Journal of patient safety. 17(8)
PURPOSE The aims of the study were to evaluate the performance of an initial list developed to detect adverse drug events (ADEs) in elderly patients with multimorbidity in clinical practice, to explore the possibility of shortening the list, and to u
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fb0b115a1cb1fd597f3c9ed9dfca77a9
https://pubmed.ncbi.nlm.nih.gov/30418424
https://pubmed.ncbi.nlm.nih.gov/30418424
Autor:
Toscano Guzmán MD, Galván Banqueri M, Otero MJ, Sánchez Fidalgo S, Font Noguera I, Pérez Guerrero MC
Publikováno v:
Journal of Patient Safety
r-IIS La Fe. Repositorio Institucional de Producción Científica del Instituto de Investigación Sanitaria La Fe
instname
r-IIS La Fe. Repositorio Institucional de Producción Científica del Instituto de Investigación Sanitaria La Fe
instname
The aims of the study were to evaluate the performance of an initial list developed to detect adverse drug events (ADEs) in elderly patients with multimorbidity in clinical practice, to explore the possibility of shortening the list, and to use this
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=RECOLECTA___::01c9e70ed20731a4f027a1f08ee802f8
https://fundanet.iislafe.san.gva.es/publicaciones/ProdCientif/PublicacionFrw.aspx?id=9547
https://fundanet.iislafe.san.gva.es/publicaciones/ProdCientif/PublicacionFrw.aspx?id=9547
Publikováno v:
Drug information and pharmacotherapy.
Background Pain is a frequent symptom with many types of cancer. In 80–85% of patients with metastatic prostate cancer (MPC), the cancer spreads to the bone, which causes pain, pathologic fractures or spinal cord compression. Purpose To develop a p
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::239e35cf7e4556d06835a7c6ccba4e49
https://doi.org/10.1136/ejhpharm-2017-000640.324
https://doi.org/10.1136/ejhpharm-2017-000640.324
Autor:
De la Fuente, A, Mayol, AS, Gonzalez, KJ, de Dios, LC, Lekue, CB, Oiartzabal, I, Ordonez, SS, Polo, SV, Chamorro, CM, Jorda, RC, Brunet, S, Sangerman, MA, Garcia, LMG, Otero, MJ, Ullrich, JMG, Gonzalez, BG, Campos, JG, Goni, JAV, Lampon, GB, Beneit, P, Lopez, AD, Perez, AR
Publikováno v:
Haematologica
r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
instname
r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
instname
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=RECOLECTA___::48b5882478cba54eff17c305ce4b2a8d
https://fundanet.igtp.cat/Publicaciones/ProdCientif/PublicacionFrw.aspx?id=6774
https://fundanet.igtp.cat/Publicaciones/ProdCientif/PublicacionFrw.aspx?id=6774